Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Cardiovascular Outcomes in Patients with Diabetes Mellitus and Heart Failure

被引：0
|
作者：
Felix Hofer
Niema Kazem
Bernhard Richter
Patrick Sulzgruber
Ronny Schweitzer
Ulrike Pailer
Andreas Hammer
Lorenz Koller
Christian Hengstenberg
Alexander Niessner
机构：
[1] Medical University of Vienna,Department of Internal Medicine II, Division of Cardiology
[2] Vienna Healthcare Group,undefined
来源：
Cardiovascular Drugs and Therapy | 2022年 / 36卷
关键词：
SGLT2i; Diabetes mellitus; Heart failure; Prescription patterns;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：497 / 504
页数：7
相关论文
共 50 条
  • [31] Meta-Analysis of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients Without Diabetes
    Mohamed, M. G. Mohamed
    Shaikh, Safia
    Osman, Mohammed
    Kheiri, Babikir
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 175 - 176
  • [32] Prescription Patterns for Sodium-Glucose Cotransporter 2 Inhibitors in US Health Systems
    Shin, Jung-Im
    Xu, Yunwen
    Chang, Alexander R.
    Carrero, Juan J.
    Flaherty, Carina M.
    Mukhopadhyay, Amrita
    Inker, Lesley A.
    Blecker, Saul B.
    Horwitz, Leora I.
    Grams, Morgan E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 683 - 693
  • [33] Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Vivian, Eva
    DIABETES EDUCATOR, 2015, 41 : 5S - 18S
  • [34] Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes Mellitus
    Sathavarodom, Nattapol
    DIABETES, 2019, 68
  • [35] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
  • [36] Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
    Baek, Jong Ha
    Yang, Ye Seul
    Ko, Seung-Hyun
    Do Han, Kyung
    Kim, Jae Hyeon
    Moon, Min Kyong
    Park, Jong Suk
    Lee, Byung-Wan
    Oh, Tae Jung
    Chon, Suk
    Choi, Jong Han
    Hur, Kyu Yeon
    DIABETES & METABOLISM JOURNAL, 2022, 46 (05) : 701 - 712
  • [37] Prescribing Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes-A Continuing Review
    Winters, Ashley
    Lopez, Miguel
    Ray, Gretchen
    Anderson, Joe R.
    DIABETES, 2024, 73
  • [38] New developments in heart failure and sodium-glucose cotransporter 2 inhibitors
    Tarraga Lopez, Pedro J.
    Iruela Martinez, Clara
    Tarraga Marcos, Loreto
    Lopez Gonzalez, Angel Arturo
    Ramirez Manent, Jose Ignacio
    MEDICINA BALEAR, 2023, 38 (02): : 144 - 156
  • [39] The Emerging Role of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure
    Gitto, Mauro
    Villaschi, Alessandro
    Federici, Massimo
    Condorelli, Gianluigi
    Stefanini, Giulio G.
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (07) : 481 - 493
  • [40] Sodium-glucose cotransporter-2 inhibitors in heart failure patients: an appraisal of recent cardiovascular outcome trials
    Kocyigit, Duygu
    Kocyigit, Alime S.
    Hussain, Muzna
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (06): : 629 - 651
12345